New research finds that adults with schizophrenia spectrum disorders have high rates of comorbid mental and substance use disorders and significant social and economic disadvantages, and only 26% received minimally adequate treatment. Meeting the needs of people with schizophrenia spectrum disorders will require innovative interventions and implementation to improve access to and use of evidence-based approaches, the authors argue.
source https://www.sciencedaily.com/releases/2024/09/240923135606.htm
Sulfolobus islandicus: Expanding the genetic toolkit for drug delivery and
biotechnology applications
-
Sulfolobus islandicus, an archaeal model organism, offers unique advantages
for metabolic engineering and synthetic biology applications owing to its
abili...
3 hours ago
No comments:
Post a Comment